Sitemap
- Home
- Notre monde
- Privacy Notice
- Conditions d’utilisation
- Avis de non-responsabilité
- Domaines thérapeutiques
- Professionnels de santé
- Portefeuille
- Produits en développement
- Généralités
- Publications
- 2023 Congresses
- 2024 Congresses
- Dang U. et al. Age, family history and genetic testing data from myotonic dystrophy patients and carers participating in ENSA survey; P65
- Díaz-Manera J et al. RevEal the burdeN on daily life for myotonic dyStrophy patients due to myotoniA: key symptom-related findings of ENSA; P66
- Late breaker: Post-authorization safety study (PASS). Mexiletine effectiveness in patients with non-dystrophic myotonia: interim analysis finding
- Sansone V. et al. Patient reported satisfaction in myotonic dystrophy management: ENSA international survey suggests benefits of Italian routine practice; P46
- Ressources pour les patients
- Contact